Osaic Holdings
SGTX

Osaic Holdings’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Osaic Holdings’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7
Closed -$157 – 7703
2023
Q2 		$157 Sell
7
-1
-13% -$7 ﹤0.01% 7239
2023
Q1 		$93 Hold
8
– – ﹤0.01% 7339
2022
Q4 		$0 Hold
8
– – ﹤0.01% 7596
2022
Q3 		$0 Hold
8
– – ﹤0.01% 7660
2022
Q2 		$0 Hold
8
– – ﹤0.01% 7741
2022
Q1 		$0 Hold
8
– – ﹤0.01% 7687
2021
Q4 		$0 Hold
8
– – ﹤0.01% 7698
2021
Q3 		$1K Buy
+8
New +$616 ﹤0.01% 7124

Other funds holding SGTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings's SGTX Position: Q3 2023 in Review

Osaic Holdings sold out of Sigilon Therapeutics, Inc. Common Stock (SGTX) in Q3 2023, closing a stake of 7 shares — an estimated $157 sold.

Osaic Holdings first reported a position in SGTX in Q3 2021 and held it in 8 quarters. The position peaked at $1K in Q3 2021. 1 fund tracked by Wall St. Rank holds SGTX as of Q3 2023.

  • Osaic Holdings reported no remaining Sigilon Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Osaic Holdings sold 7 Sigilon Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $157.
  • Osaic Holdings first reported a position in Sigilon Therapeutics, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
  • Osaic Holdings's Sigilon Therapeutics, Inc. Common Stock position peaked at $1K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Sigilon Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.